The purpose of this pilot study is to generate data to assess feasibility of study
design/procedures and for formal sample size estimation for a larger multicenter study of the
efficacy and safety of sirolimus in infants with medically-unresponsive congenital
hyperinsulinism (HI) due to inactivating mutations of adenosine triphosphate-sensitive
potassium (KATP) channels.